Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MAIA Biotechnology, Inc. Common Stock (NY:MAIA)

1.630 +0.100 (+6.54%)
Official Closing Price Updated: 8:00 PM EST, Jan 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about MAIA Biotechnology, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
MAIA Biotechnology Doses First Patients in Europe in Ongoing Phase 2 Trial (THIO-101) Evaluating THIO for Non-Small Cell Lung Cancer Treatment
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023 ↗
 
Via Benzinga
News headline image
ADDING MULTIMEDIA: MAIA Biotechnology’s Telomere-targeting Agent THIO, in Combination With Checkpoint Inhibitor Immune Therapies Atezolizumab (anti-PD-L1) or Pembrolizumab (anti-PD-1), Demonstrated Significantly Greater Tumor Inhibition
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
Insiders Buying Adamas One And 1 Other Penny Stock ↗
The Nasdaq recorded gains for the fourth week in a row. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested... 
Via Benzinga
News headline image
Sidoti's January Micro-Cap Conference
Via ACCESSWIRE
News headline image
MAIA Biotechnology Advances New Telomere-Targeting Molecule Program
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
MAIA Biotechnology to Participate in Four Upcoming Investor Conferences
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
CalAmp And 2 Other Stocks Under $5 Insiders Are Aggressively Buying ↗
The Dow Jones settled higher by over 300 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
News headline image
MAIA Biotechnology Holds Successful Pre-IND Meeting with FDA for Planned US Expansion of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
MAIA Biotechnology Expands Phase 2 THIO-101 Trial to Europe
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
MAIA Biotechnology Announces Establishment of Rule 10b5-1 Trading Plan
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
MAIA Biotechnology Presents Preclinical Data at SITC Annual Meeting Validating Efficacy of THIO in Treating Hepatocellular Carcinoma
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
MAIA Biotechnology Reports Third Quarter 2022 Financial Results and Provides Corporate Update
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
Sidoti's November Micro-Cap Virtual Conference
Via ACCESSWIRE
News headline image
MAIA Biotechnology to Participate in ThinkEquity Conference
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
MAIA Biotechnology to Present at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
MAIA Biotechnology to Participate in H.C. Wainwright 24th Annual Global Investment Conference
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
MAIA Biotechnology to Present Design of THIO-101 Trial at European Society for Medical Oncology (ESMO) Congress 2022
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
MAIA Biotechnology to Present Anticancer THIO Platform at XIV International Round Table on Nucleosides, Nucleotides, and Nucleic Acids
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
MAIA Biotechnology Reports Second Quarter 2022 Financial Results and Provides Corporate Update
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
Opening Day: Hong Kong's GigaCloud Jumps In Nasdaq Debut ↗
Shares of Hong Kong-based online marketplace provider GigaCloud jumped almost 30% in its debut earlier this week. It opened at $19.20 on Thursday, up 57% from its original price of $12.25 per share.... 
Via Talk Markets
News headline image
This Healthcare Stock Is Trading Higher By 148%: Here Are 40 Stocks Moving Premarket ↗
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares rose 159.3% to $1.67 in pre-market trading after dropping 13% on Tuesday. 
Via Benzinga
News headline image
This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday ↗
Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume. 
Via Benzinga
News headline image
Why Poseida Therapeutics Is Trading Higher By Around 100%, Here Are 75 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
It's time for another dive into the biggest pre-market stock movers as we check out the latest news investors need to know about Wednesday! 
Via InvestorPlace
News headline image
MAIA Biotechnology Receives FDA Orphan Drug Designation for THIO for the Treatment of Small-Cell Lung Cancer (SCLC)
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
MAIA Biotechnology Announces Closing of Initial Public Offering
From MAIA Biotechnology, Inc.
Via Business Wire
News headline image
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday ↗
Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks. 
Via Benzinga
News headline image
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday ↗
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday. 
Via Benzinga
News headline image
This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.